These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2525802)

  • 1. The effect of cyclosporin A in murine visceral leishmaniasis.
    Olivier M; Tanner CE
    Trop Med Parasitol; 1989 Mar; 40(1):32-8. PubMed ID: 2525802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of lymphokines in the control of multiplication and dispersion of Leishmania donovani within liver macrophages of resistant and susceptible mice.
    Olivier M; Proulx C; Tanner CE
    J Parasitol; 1989 Oct; 75(5):720-7. PubMed ID: 2529362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
    Kaye PM; Curry AJ; Blackwell JM
    J Immunol; 1991 Apr; 146(8):2763-70. PubMed ID: 1901883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
    Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM
    Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells.
    Nickol AD; Bonventre PF
    Infect Immun; 1985 Oct; 50(1):160-8. PubMed ID: 2931376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.
    Mullen AB; Lawrence CE; McFarlane E; Wei XQ; Carter KC
    Immunology; 2006 Nov; 119(3):348-54. PubMed ID: 16879623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 2/interleukin 4-independent T helper cell generation during an in vitro antigenic stimulation of mouse spleen cells in the presence of cyclosporin A.
    Motta I; Colle JH; Shidani B; Truffa-Bachi P
    Eur J Immunol; 1991 Mar; 21(3):551-7. PubMed ID: 1672640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killing of Leishmania donovani by activated liver macrophages from resistant and susceptible strains of mice.
    Olivier M; Bertrand S; Tanner CE
    Int J Parasitol; 1989 Jul; 19(4):377-83. PubMed ID: 2777460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclosporin A on T cell immunity. II. Defective thymic education of CD4 T helper cell function in cyclosporin A-treated mice.
    Fukuzawa M; Sharrow SO; Shearer GM
    Eur J Immunol; 1989 Jun; 19(6):1147-52. PubMed ID: 2568932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cyclosporin on major histocompatibility complex-linked resistance to murine cytomegalovirus.
    Lawson CM; Hodgkin PD; Shellam GR
    J Gen Virol; 1989 May; 70 ( Pt 5)():1253-9. PubMed ID: 2543779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithymocyte serum suppression of immunity in mice immunized to Leishmania donovani.
    Runey GL; Jarecki-Black JC; Runey MW; Glassman AB
    Ann Clin Lab Sci; 1990; 20(4):263-7. PubMed ID: 2403241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
    Rachamim N; Jaffe CL
    J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
    Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
    Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin.
    Reiner NE; Finke JH
    J Immunol; 1983 Sep; 131(3):1487-91. PubMed ID: 6224858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rIL-2-stimulated splenocytes reactivate the NO2-producing ability of macrophages infected by Leishmania donovani.
    Eslami Z; Tanner CE
    Immunopharmacol Immunotoxicol; 2000 Aug; 22(3):465-87. PubMed ID: 10946826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
    Holaday B; Sadick MD; Pearson RD
    J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cyclosporin A on murine and human T helper cell clones.
    Fidelus RK; Ferguson RM; Widmer MB; Wee SL; Bach FH; Orosz CG
    Transplantation; 1982 Nov; 34(5):308-11. PubMed ID: 6218659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.